Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL9 Receptor antibody (Extracellular Domain)

This anti-IL9 Receptor antibody is a Mouse Monoclonal antibody detecting IL9 Receptor in ELISA, FACS, Func and Neut. Suitable for Human.
Catalog No. ABIN327384

Quick Overview for IL9 Receptor antibody (Extracellular Domain) (ABIN327384)

Target

See all IL9 Receptor (IL9R) Antibodies
IL9 Receptor (IL9R) (Interleukin 9 Receptor (IL9R))

Reactivity

  • 42
  • 20
  • 2
Human

Host

  • 33
  • 12
  • 2
Mouse

Clonality

  • 31
  • 15
  • 1
Monoclonal

Conjugate

  • 30
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This IL9 Receptor antibody is un-conjugated

Application

  • 26
  • 24
  • 22
  • 10
  • 6
  • 4
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
ELISA, Flow Cytometry (FACS), Functional Studies (Func), Neutralization (Neut)
  • Binding Specificity

    • 7
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain

    Specificity

    Recognizes human IL-9R. In direct ELISAs, this antibody does not cross-react with rhIL-4 R, rhIL-5 R, rhIL-5 R, rhIL-13 R 1, rhIL-13 R 2, or rmIL-9 R.

    Purification

    Protein G purified

    Immunogen

    Sf21-derived rhIL-9 R extracellular domain.

    Type of Immunogen: Recombinant protein

    Isotype

    IgG1
  • Application Notes

    Approved: ELISA, Flo, Func, Neut

    Usage: Neutralization of bioactivity, Flow Cytometry, Direct ELISA. Neutralization of Human IL-9 Receptor-mediated bioactivity: The exact concentration of antibody required to neutralize the human cell surface IL-9 R mediated bioactivity is dependent on the IL-2 concentration as well as on the number and types of IL-2 receptors present on the cell surface (a function of cell type and culture conditions). The Neutralization Dose50 (ND50) for this antibody is defined as that concentration of antibody required to yield one-half maximal inhibition of the cell surface IL-9 R mediated IL-9 response on a responsive cell line, at a specific IL-9 concentration. The ND50 for this lot of anti-human IL-9 R antibody was determined to be approximately 2-4 μg/mL for inhibiting the IL-9-dependent proliferation of MO7e cells (1 x 10^5 cells/mL) in the presence of 2 ng/mL of rhIL-9. Flow Cytometry: This antibody was validated for flow cytometry using blood-derived monocytes. Dilute this antibody to 50 μg/mL and add 10 μL of the diluted solution to 1-2.5 x 10^5 cells in a total reaction volume not exceeding 200 μL. The binding of unlabeled antibodies may be visualized by adding a secondary developing reagent such as anti-mouse IgG conjugated to a fluorochrome. Direct ELISA: This antibody can be used at 0.5-1.0 μg/mL with the appropriate secondary reagents to detect human IL-9 R. The detection limit for rhIL-9 R is approximately 6 ng/well.

    Comment

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstitution: Reconstitute, sterile PBS. If 1 mL of PBS is used, the antibody concentration will be 500 μg/mL.

    Concentration

    Lot specific

    Buffer

    Lyophilized from PBS, 5 % trehalose. Reconstitution: Reconstitute, sterile PBS. If 1 mL of PBS is used, the antibody concentration will be 500 μg/mL.
  • Target

    IL9 Receptor (IL9R) (Interleukin 9 Receptor (IL9R))

    Alternative Name

    IL9R / CD129

    Background

    Name/Gene ID: IL9R
    Family: Interleukin

    Synonyms: IL9R, IL-9 receptor, IL-9R, Interleukin 9 receptor, Interleukin-9 receptor, CD129, CD129 antigen

    Gene ID

    3581

    UniProt

    Q01113

    Pathways

    JAK-STAT Signaling, Growth Factor Binding
You are here:
Chat with us!